Related Experiment Video
Updated: Oct 5, 2025
Author Spotlight: Exploring Strategies for Successful Immune Response Against Tumors
Published on: August 16, 2024
Microdissection Methods Utilizing Single-Cell Subtype Analysis and the Impact on Precision Medicine
Donald J Johann1, Sarah Laun2, Ik Jae Shin1
1Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Abstract:
Improving the utilization of tumor tissue from diagnostic biopsies is an unmet medical need. This is especially relevant today in the rapidly evolving precision oncology field where tumor genotyping is often essential for the indication of many advanced and targeted therapies. National Comprehensive Cancer Network (NCCN) guidelines now mandate molecular testing for clinically actionable targets in certain malignancies. Utilizing advanced stage lung cancer as an example, an improved genotyping approach for solid tumors is possible. The strategy involves optimization of the microdissection process and analysis of a large number of identical target cells from formalin-fixed paraffin-embedded (FFPE) specimens sharing similar characteristics, in other words, single-cell subtype analysis. The shared characteristics can include immunostaining status, cell phenotype, and/or spatial location within a histological section. Synergy between microdissection and droplet digital PCR (ddPCR) enhances the molecular analysis. We demonstrate here a methodology that illustrates genotyping of a solid tumor from a small tissue biopsy sample in a time- and cost-efficient manner, using immunostain targeting as an example.
Insights
Maximizing tumor tissue from biopsies is crucial for precision oncology. This new method uses optimized microdissection and droplet digital PCR for efficient single-cell subtype analysis in solid tumors.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Precision oncology relies on accurate tumor genotyping for targeted therapies.
- National Comprehensive Cancer Network guidelines recommend molecular testing for specific cancers.
- Current methods often face limitations with small diagnostic biopsy samples.
Purpose of the Study:
- To develop an improved method for solid tumor genotyping from limited biopsy material.
- To enhance the utilization of tumor tissue for molecular analysis in precision medicine.
- To demonstrate a cost- and time-efficient genotyping approach.
Main Methods:
- Optimization of the microdissection process for formalin-fixed paraffin-embedded (FFPE) specimens.
- Single-cell subtype analysis based on shared characteristics like immunostaining or spatial location.
- Synergistic application of microdissection with droplet digital PCR (ddPCR) for molecular analysis.
Main Results:
- Demonstrated a methodology for genotyping solid tumors from small biopsy samples.
- Achieved time- and cost-efficient molecular analysis.
- Successfully utilized immunostaining as an example for target identification.
Conclusions:
- The described methodology improves tumor tissue utilization for genotyping.
- This approach supports precision oncology by enabling detailed molecular analysis from limited samples.
- Optimized microdissection combined with ddPCR offers an efficient solution for advanced cancer diagnostics.
More Related Videos
09:34A Combinatorial Single-cell Approach to Characterize the Molecular and Immunophenotypic Heterogeneity of Human Stem and Progenitor Populations
Published on: October 25, 2018
08:19Author Spotlight: Shear Assay Protocol for the Determination of Single-Cell Material Properties
Published on: May 19, 2023